Biotech

Eggs used to grow viruses for flu shots trigger changes that leave people vulnerable

The controversial approach aims to rejuvenate old tissue

Experts debate what amateur scientists could accomplish with the powerful DNA editing tool—and whether its ready availability is cause for concern 

Neuroscientist Christof Koch calls for a “crash program” in brain technologies to make us smarter

Biofilms—3-D mats of bacteria—kill as many people as cancer does and fight off antibiotics. Now scientists are turning biofilms’ own weapons against them

The audit recommends an overhaul of the Select Agent Program

This tool could, in theory, fix genetic mistakes that lead to about 15,000 illnesses

A company called Kick wants to market to the masses a heart medication that would be used for reversing stage fright. Some medical professionals are getting agitated

A compound that helps rodents and monkeys slim down could offer a promising approach for human therapies

Scientists have successfully edited the genes of human embryos. What does this mean for the future of genetic engineering?

The $215-million infusion will support immunotherapy work

Shutting down the top risk gene holds potential for halting the disease process